Insight Strategy Advisors’s abstract submission for the 2010 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS.eu ) Conference in Göteberg, Sweden has been accepted for publication.

The study, entitled “Impact of Multiple Sclerosis Disease-modifying Drugs on Health Care Costs: Application to the Swedish Health System,” analyzed the impact of adherence to disease-modifying therapy (DMT) for MS-related high-cost events in Sweden. This achievement represents an innovative approach to quantifying the cost-impact of non-adherence in a European environment.

“This study answers an unmet need that many government budget-holders and pharmaceutical executives have. This information can enhance discussions that government budget-holders, physician budget-holders and pharmaceutical companies are having around the importance of adherence and value-add programs to promote compliance,” remarked Cyrus A. Chowdhury, Vice President of the Global Market Access practice at Insight Strategy Advisors.

“We applied Swedish costs of events to patient-level claims and clinical data to help our clients answer long-standing cost-effectiveness questions in Europe,” explains Elena Castañeda, Analyst at Insight Strategy Advisors.
The 2010 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS.eu ) conference in Göteberg will take place October 13-16, 2010 in Göteberg, Sweden. Interested parties can learn more about this and other global healthcare topics by contacting Mr. Chowdhury directly at cyrus.chowdhury@insightstrat.com.

ISA has a global network of market experts who advise on all engagements, as well as an experienced multinational team of consultants headquartered in New York City, with presence in Geneva and Philadelphia. Other practice areas include Commercialization Strategy, Oncology & Specialty Therapeutics, and US Managed Markets.

The Global Market Access practice at Insight Strategy Advisors provides pharmaceutical and biotechnology companies advisory services for maximizing market access across the global marketplace. Engagements include, but are not limited to, pricing and market access assessments, portfolio optimization strategies, partnership due diligence, and NGO facilitation.